Efficacy of Scintigraphy, Ultrasound and Both Scintigraphy and Ultrasonography in Preoperative Detection and Localization of Primary Hyperparathyroidism

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2019 Aug 28

PMID 31453033

Citations 4

Authors

Wafaa Abd Elhameed Elsayed

Rasha A Ali

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of our study was to evaluate the efficacy of preoperative dual-phase 99mTc-methoxyisobutylnitrile (MIBI) parathyroid scintigraphy (PS), and ultrasound (US) in primary hyperparathyroidism (pHPT) diagnosis and compare the results with the surgical findings.

Methods: Forty-five patients were enrolled in this study. Preoperative serum parathyroid hormone (PTH) levels, calcium (Ca), phosphate (P), and alkaline phosphatase (AP) levels were measured. All parathyroid patients were evaluated by ultrasonography, dual phase 99mTc-MIBI. Surgical findings were used as a reference standard.

Results: Of the 45 patients included in this study, 30 were females (66.7%) with an age range between 30 years and 70 years (mean age 41± 13). The sensitivity and specificity of 99mTc-MIBI scintigraphy was 97.4% and 71.4%, respectively, while the sensitivity of ultrasound was 94.4% and specificity 44.4%. The sensitivity, specificity, and accuracy of combined scintigraphy and ultrasound was higher-97.4%, 83.3%, and 95.6%, respectively.

Conclusions: The combination of MIBI and US appears promising for localizing parathyroid pathology in patients with primary hyperparathyroidism. The concordance rate is high together with a lower chance of missing concomitant thyroid pathology, which might alter the surgical approach.

Citing Articles

Four-dimensional computed tomography as first-line imaging in primary hyperparathyroidism, a retrospective comparison to conventional imaging in a predominantly single adenoma population.

Krol J, Joosten F, de Boer H, Bernsen M, Slump C, Oyen W EJNMMI Rep. 2024; 8(1):11.

PMID: 38748330 PMC: 11061064. DOI: 10.1186/s41824-024-00198-5.

Characteristics, management and outcomes of primary hyperparathyroidism from 2009 to 2021: a single centre report from South Africa.

Govind K, Paruk I, Motala A BMC Endocr Disord. 2024; 24(1):53.

PMID: 38664758 PMC: 11044279. DOI: 10.1186/s12902-024-01583-8.

Can we skip technetium-99 m sestamibi scintigraphy in pediatric primary hyperparathyroidism patients with positive neck ultrasound results?.

He Y, Luo Y, Jin S, Wang O, Liao Q, Zhu Q Pediatr Radiol. 2023; 53(11):2253-2259.

PMID: 37438472 PMC: 10562501. DOI: 10.1007/s00247-023-05702-w.

The Utility of Ultrasound in the Preoperative Localization of Primary Hyperparathyroidism: Insights from Pakistan.

Fatima T, Das B, Sattar S, Jabeen S, Khan A, Islam N Cureus. 2020; 12(8):e9835.

PMID: 32953342 PMC: 7496491. DOI: 10.7759/cureus.9835.

References

Purcell G, Dirbas F, Jeffrey R, Lane M, Desser T, McDougall I . Parathyroid localization with high-resolution ultrasound and technetium Tc 99m sestamibi. Arch Surg. 1999; 134(8):824-8; discussion 828-30. DOI: 10.1001/archsurg.134.8.824. View

De Feo M, Colagrande S, Biagini C, Tonarelli A, Bisi G, Vaggelli L . Parathyroid glands: combination of (99m)Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology. 2000; 214(2):393-402. DOI: 10.1148/radiology.214.2.r00fe04393. View

Lumachi F, Zucchetta P, Varotto S, Polistina F, Favia G, DAmico D . Noninvasive localization procedures in ectopic hyperfunctioning parathyroid tumors. Endocr Relat Cancer. 2000; 6(1):123-5. DOI: 10.1677/erc.0.0060123. View

Marx S . Hyperparathyroid and hypoparathyroid disorders. N Engl J Med. 2000; 343(25):1863-75. DOI: 10.1056/NEJM200012213432508. View

Lumachi F, Zucchetta P, Marzola M, Boccagni P, Angelini F, Bui F . Advantages of combined technetium-99m-sestamibi scintigraphy and high-resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism. Eur J Endocrinol. 2000; 143(6):755-60. DOI: 10.1530/eje.0.1430755. View

Tolloczko T, Chudzinski W, Nawrot I . Surgery for primary hyperparathyroidism. Przegl Lek. 2001; 57 Suppl 5:101-3. View

Wakamatsu H, Noguchi S, Yamashita H, Tamura S, Jinnouchi S, Nagamachi S . Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US. Eur J Nucl Med. 2001; 28(12):1817-27. DOI: 10.1007/s002590100627. View

Melton 3rd L . The epidemiology of primary hyperparathyroidism in North America. J Bone Miner Res. 2002; 17 Suppl 2:N12-7. View

Wei J, Burke G, MANSBERGER Jr A . Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands. Surgery. 1992; 112(6):1111-6; discussion 1116-7. View

10.

Ruda J, Hollenbeak C, Stack Jr B . A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg. 2005; 132(3):359-72. DOI: 10.1016/j.otohns.2004.10.005. View

11.

Wermers R, Khosla S, Atkinson E, Achenbach S, Oberg A, Grant C . Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2005; 21(1):171-7. DOI: 10.1359/JBMR.050910. View

12.

Solorzano C, Carneiro-Pla D, Irvin 3rd G . Surgeon-performed ultrasonography as the initial and only localizing study in sporadic primary hyperparathyroidism. J Am Coll Surg. 2005; 202(1):18-24. DOI: 10.1016/j.jamcollsurg.2005.08.014. View

13.

Mihai R, Wass J, Sadler G . Asymptomatic hyperparathyroidism--need for multicentre studies. Clin Endocrinol (Oxf). 2007; 68(2):155-64. DOI: 10.1111/j.1365-2265.2007.02970.x. View

14.

Sukan A, Reyhan M, Aydin M, Yapar A, Sert Y, Canpolat T . Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging. Ann Nucl Med. 2008; 22(2):123-31. DOI: 10.1007/s12149-007-0086-z. View

15.

Tublin M, Pryma D, Yim J, Ogilvie J, Mountz J, Bencherif B . Localization of parathyroid adenomas by sonography and technetium tc 99m sestamibi single-photon emission computed tomography before minimally invasive parathyroidectomy: are both studies really needed?. J Ultrasound Med. 2009; 28(2):183-90. DOI: 10.7863/jum.2009.28.2.183. View

16.

Hindie E, Ugur O, Fuster D, ODoherty M, Grassetto G, Urena P . 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009; 36(7):1201-16. DOI: 10.1007/s00259-009-1131-z. View

17.

Tresoldi S, Pompili G, Maiolino R, Flor N, De Pasquale L, Bastagli A . Primary hyperparathyroidism: can ultrasonography be the only preoperative diagnostic procedure?. Radiol Med. 2009; 114(7):1159-72. DOI: 10.1007/s11547-009-0447-x. View

18.

Nasiri S, Soroush A, Hashemi A, Hedayat A, Donboli K, Mehrkhani F . Parathyroid adenoma Localization. Med J Islam Repub Iran. 2013; 26(3):103-9. PMC: 3587906. View

19.

Coakley A, Kettle A, Wells C, ODoherty M, Collins R . 99Tcm sestamibi--a new agent for parathyroid imaging. Nucl Med Commun. 1989; 10(11):791-4. DOI: 10.1097/00006231-198911000-00003. View

20.

Crane P, LALIBERTE R, Heminway S, Thoolen M, Orlandi C . Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med. 1993; 20(1):20-5. DOI: 10.1007/BF02261241. View